Investigator Sponsored Trials
Our Investigator-Sponsored Trials (IST) program provides support for external clinical research that advances medical and/or scientific knowledge about our products, with the goal of enhancing patient care. Our current IST program supports hematology/oncology indications and will consider protocols based on a strong scientific rationale.
The objective of our IST program is to provide funding and/or study drug for clinical research that will address unmet medical needs with new scientific data and support pilot studies that explore the feasibility of new treatments.
Potential Areas of Interest
- New combination therapies
- Earlier line of treatment
- New/different doses and schedules of panobinostat
- Combination therapies
Submit a Proposal
To submit a proposal to Secura Bio, complete the online form and email it to
For questions related to form submission, please email IST@securabio.com.